Provectus Biopharmaceuticals Inc (PVCT)

[tim779]

No, I don't think they say this after every halt:

NYSE Regulation will carefully consider the price indications obtained in the opening process and will assess whether to move to continue to halt or suspend trading in the Company’s securities should the: (1) price indications or subsequent trading reflect a price that the NYSE MKT deems to be “abnormally low”; (2) NYSE MKT receive authoritative advice that the security is without value; or (3) Company fall below the quantitative continued listing standards listed in the NYSE MKT Company Guide. NYSE Regulation will continue to closely monitor events at the Company and the appropriateness of continued listing of the Company’s securities.

I'd say de-listing is likely and they are just preparing the ground work. Just trying to inject a bit of realism here amid all the denial and wishful thinking.